Skip to main content
SpringerLink
Log in

Antineoplastics/ribavirin

Anaemia, lack of efficacy and hepatitis-C infection exacerbation: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Yamazaki T, et al. Successful treatment by glecaprevir/pibrentasvir followed by hepatoprotective therapy of acute chronic hepatitis exacerbation caused by daratumumab-based regimen for multiple myeloma: Case report and review of the literature. Journal of Infection and Chemotherapy : no pagination, Jan 2021. Available from: URL: http://www.journals.elsevier.com/journal-of-infection-and-chemotherapy/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics/ribavirin. Reactions Weekly 1870, 46 (2021). https://doi.org/10.1007/s40278-021-01256-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-01256-x

Search

Navigation